Get the full picture
Sign in to uncover key details.
DiaMedica Therapeutics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
301 Carlson Pkwy Ste 210, Hopkins, Minne...Phone Number
(763) 496-5454Website
www.diamedica.comRevenue
$22.4 MillionStock Symbol
DMACIndustry
About DiaMedica Therapeutics
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from preeclampsia and acute ischemic stroke. DiaMedicas lead candidate, DM199, is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treatment of acute ischemic stroke, preeclampsia and other vascular diseases.Explore more
DiaMedica Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to DiaMedica Therapeutics
Compare insights from companies similar to DiaMedica Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
DiaMedica Therapeutics Tech Stack
A closer look at the technologies used by DiaMedica Therapeutics
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding DiaMedica Therapeutics
Sign Up For FreeTo access detailed company insights
DiaMedica Therapeutics Inc. is a clinical stage biopharmaceutical company committed to improving the lives of people suffering from preeclampsia and acute ischemic stroke. DiaMedicas lead candidate, DM199, is the first pharmaceutically active recombinant (synthetic) form of the KLK1 protein, an established therapeutic modality in Asia for the treat... Read More
